Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1751741000168110 | Ostelin Osteoguard (boric acid 8.6 mg + calcium carbonate 1.5 g + colecalciferol 12.5 microgram + magnesium (as citrate nonahydrate) 21.43 mg + magnesium (as oxide heavy) 31.07 mg + manganese (as sulfate monohydrate) 2 mg + phytomenadione 100 microgram) film-coated tablet, 90 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1751751000168112 | Ostelin Osteoguard film-coated tablet, 90, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ostelin Osteoguard film-coated tablet, 90, blister pack | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Ostelin Osteoguard film-coated tablet, 90, blister pack | Is a | Ostelin Osteoguard film-coated tablet, 90 | false | Inferred relationship | Some | ||
| Ostelin Osteoguard film-coated tablet, 90, blister pack | has TPUU | Ostelin Osteoguard film-coated tablet | false | Inferred relationship | Some | ||
| Ostelin Osteoguard film-coated tablet, 90, blister pack | has container type | blister pack | false | Inferred relationship | Some | ||
| Ostelin Osteoguard film-coated tablet, 90, blister pack | has TP | Ostelin Osteoguard | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR